NewAmsterdam Pharma N.V. Balance Sheet
NASDAQ: NAMSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
NewAmsterdam Pharma N.V. financial position
At the end of fiscal 2025, NewAmsterdam Pharma N.V. reported total assets of $769.3 million, down 11.0% from a year earlier against total liabilities of $85.9 million. Shareholders' equity stood at $683.4 million, or 88.8% of assets. The company held $490.0 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 7.88, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
NewAmsterdam Pharma N.V. balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 |
|---|---|---|---|---|---|
| Cash & Equivalents | 490.00M | 771.74M | 340.45M | 467.73M | — |
| Short-Term Investments | 146.24M | 62.45M | — | — | — |
| Total Current Assets | 675.70M | 863.41M | 346.79M | 477.98M | — |
| Property, Plant & Equipment | 383.00K | 242.00K | 46.00K | 34.00K | — |
| Long-Term Investments | 92.61M | — | — | — | — |
| Total Assets | 769.28M | 864.62M | 347.10M | 478.50M | — |
| Accounts Payable | 8.97M | 4.74M | 16.92M | 11.85M | — |
| Total Current Liabilities | 85.79M | 106.92M | 49.90M | 36.06M | — |
| Total Liabilities | 85.85M | 107.12M | 58.70M | 48.43M | — |
| Shareholders' Equity | 683.43M | 757.50M | 288.39M | 430.07M | -113.82M |
| Retained Earnings | -762.39M | -558.57M | -316.97M | -140.04M | — |
| Net Cash (Debt) | 636.24M | 834.19M | 340.45M | 467.73M | — |
| Shares Outstanding | 114.40M | 108.06M | 82.47M | 81.56M | 11.33M |
This table shows 5 annual periods of NewAmsterdam Pharma N.V.'s balance sheet, from FY 2025 back to FY 2021, across 13 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow NAMS's reporting calendar. What is a balance sheet?